Invitrogen™ Retifanlimab Chimeric Recombinant Human Monoclonal Antibody

Human Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA542287

Catalog No. PIMA542287

Description

Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.

Retifanlimab (INCMGA-0012) is an anti-PD-1 monoclonal antibody. INCMGA0012 is currently in the clinical proof-of-concept (PoC) stage. At the same time, Incyte is exploring the efficacy of INCMGA0012 monotherapy in high satellite unstable endometrial cancer and Merkel cell carcinoma.

Specifications

• Antigen: Retifanlimab Chimeric
• Classification: Recombinant Monoclonal
• Conjugate: Unconjugated
• Gene Alias: INCMGA-00012; MGA-012
• Immunogen: Human PDCD1/PD1/CD279.
• Quantity: 100 μg
• Primary or Secondary: Primary
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Form: Liquid
• Target Molecule: Chemical

• Applications: ELISA, SDS-Page
• Concentration: 1 mg/mL
• Formulation: PBS with no preservative; pH 7.4
• Host Species: Human
• Purification Method: Protein A
• Regulatory Status: RUO
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG4 κ

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov